Bristol Myers Squibb to Present at J.P. Morgan’s 39th Annual Virtual Healthcare Conference

- January 4th, 2021

Bristol Myers Squibb today announced that the company will present at J.P. Morgan’s 39 th Annual Virtual Healthcare Conference, which will be webcast on Monday, January 11, 2021. Giovanni Caforio M.D., Board Chair and Chief Executive Officer will make a formal presentation and answer questions about the company at 7:30 a.m. EST. Investors and the general public are invited to listen to a live webcast of the …

Bristol Myers Squibb (NYSE: BMY) today announced that the company will present at J.P. Morgan’s 39 th Annual Virtual Healthcare Conference, which will be webcast on Monday, January 11, 2021. Giovanni Caforio , M.D., Board Chair and Chief Executive Officer will make a formal presentation and answer questions about the company at 7:30 a.m. EST.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com . Material related to the company’s presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn , Twitter , YouTube , Facebook , and Instagram .

Corporatefinancial_news

Bristol Myers Squibb

Media:
media@bms.com

Investor Relations:
Tim Power
609-252-7509
timothy.power@bms.com

Nina Goworek
908-673-9711
nina.goworek@bms.com

News Provided by Business Wire via QuoteMedia

  Life Science and Healthcare Investing report cover

Life Science and Healthcare Investing in 2021

 
The life science and healthcare market is a booming, multi-billion dollar industry. Read our 2021 life science outlook report!
 

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select None
Select All

Leave a Reply